This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials.
Now he’s raised some $615 million from top investors to buy stalled drugs and use AI to stress test them faster.
Benjamine Liu was a young computational biologist working on his doctorate at the University of Oxford, he had some ideas for novel drugs that could treat Alzheimer’s.
He was so excited by their promise that he tried shopping them around to a few pharmaceutical companies. Not a single one was interested.
